Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 11 2020
Historique:
received: 05 07 2020
accepted: 17 11 2020
entrez: 1 12 2020
pubmed: 2 12 2020
medline: 12 3 2021
Statut: epublish

Résumé

In this study, we examined the fluctuation in radioresponse of HeLa cells during the cell cycle. For this purpose, we used HeLa cells expressing two types of fluorescent ubiquitination-based cell cycle indicators (Fucci), HeLa-Fucci (CA)2 and HeLa-Fucci (SA), and combined this approach with the micronucleus (MN) assay to assess radioresponse. The Fucci system distinguishes cell cycle phases based on the colour of fluorescence and cell morphology under live conditions. Time-lapse imaging allowed us to further identify sub-positions within the G1 and S phases at the time of irradiation by two independent means, and to quantitate the number of MNs by following each cell through M phase until the next G1 phase. Notably, we found that radioresponse was low in late G1 phase, but rapidly increased in early S phase. It then decreased until late S phase and increased in G2 phase. For the first time, we demonstrated the unique fluctuation of radioresponse by the MN assay during the cell cycle in HeLa cells. We discuss the difference between previous clonogenic experiments using M phase-synchronised cell populations and ours, as well as the clinical implications of the present findings.

Identifiants

pubmed: 33257719
doi: 10.1038/s41598-020-77969-0
pii: 10.1038/s41598-020-77969-0
pmc: PMC7705701
doi:

Substances chimiques

Fluorescent Dyes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20873

Références

Int J Radiat Biol. 2003 Jan;79(1):61-8
pubmed: 12556332
Biophys J. 1967 Jan;7(1):77-94
pubmed: 19210983
Sci Adv. 2020 Jan 08;6(2):eaay0922
pubmed: 31934630
Int J Mol Sci. 2020 Feb 24;21(4):
pubmed: 32102335
Biophys J. 1963 Jan;3:11-33
pubmed: 13980635
Cell Biol Int. 2011 Apr;35(4):359-63
pubmed: 21231917
Mutat Res. 2011 Jun 3;711(1-2):61-72
pubmed: 21329706
J Radiat Res. 2019 Oct 23;60(5):709-713
pubmed: 31347653
Annu Rev Cell Dev Biol. 2020 Oct 6;36:85-114
pubmed: 32692592
PLoS One. 2015 Dec 30;10(12):e0145995
pubmed: 26716455
Int J Radiat Biol. 1990 Aug;58(2):303-11
pubmed: 1974577
Mol Cell. 2014 Jan 9;53(1):7-18
pubmed: 24316220
Nature. 1963 Sep 21;199:1158-60
pubmed: 14072031
Cell. 2015 Dec 17;163(7):1641-54
pubmed: 26687355
DNA Repair (Amst). 2009 Oct 2;8(10):1225-34
pubmed: 19683478
DNA Repair (Amst). 2015 Mar;27:28-39
pubmed: 25629437
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195692
Int J Oncol. 2003 Dec;23(6):1593-9
pubmed: 14612931
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2977-2983
pubmed: 30119887
Cancer Sci. 2017 Apr;108(4):704-712
pubmed: 28135769
Exp Cell Res. 2015 Dec 10;339(2):389-96
pubmed: 26500111
Nature. 1961 Jun 24;190:1210-11
pubmed: 13775960
Cell. 2008 Feb 8;132(3):487-98
pubmed: 18267078
Mol Cell Endocrinol. 1996 Feb 5;116(2):227-32
pubmed: 8647324
Exp Cell Res. 1963 Apr;30:344-62
pubmed: 13980637
Nat Commun. 2016 Sep 19;7:12889
pubmed: 27641979
Biophys J. 1965 Jan;5:1-25
pubmed: 14284327
Sci Rep. 2016 Aug 02;6:30689
pubmed: 27480052
Mol Cell. 2017 Nov 2;68(3):626-640.e5
pubmed: 29107535
Radiat Res. 1968 Mar;33(3):620-43
pubmed: 4867897
Radiat Res. 1966 Nov;29(3):450-74
pubmed: 5924188
Methods. 2007 Feb;41(2):143-50
pubmed: 17189856
PLoS One. 2015 Jun 18;10(6):e0128090
pubmed: 26086724

Auteurs

Hiroaki Shimono (H)

Division of Oral Health Sciences, Department of Oral Radiation Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.
Division of Oral Health Sciences, Department of Oral and Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Atsushi Kaida (A)

Division of Oral Health Sciences, Department of Oral Radiation Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Hisao Homma (H)

Division of Oral Health Sciences, Department of Oral Radiation Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Hitomi Nojima (H)

Division of Oral Health Sciences, Department of Oral Radiation Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Yusuke Onozato (Y)

Division of Oral Health Sciences, Department of Oral Radiation Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Hiroyuki Harada (H)

Division of Oral Health Sciences, Department of Oral and Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan.

Masahiko Miura (M)

Division of Oral Health Sciences, Department of Oral Radiation Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8549, Japan. masa.mdth@tmd.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH